Just in!!
Recce Pharmaceuticals Equity Research Report Sydney Australia, 16 June 2021: Recce Pharmaceuticals Ltd (ASX: RCE) (FSE: R9Q) (Company), the Company developing New Classes of Synthetic Anti-infectives, is pleased to present MST's equity research coverage on Recce titled:
New, Nimble Drugs to Fight Bad, Strong Bugs.
RCE Charts, page-1235
-
- There are more pages in this discussion • 938 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.3M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 55.5¢ | 54.0¢ | $10.82K | 19.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1228 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 7060 | 5 |
View Market Depth
| Last trade - 14.29pm 16/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |